You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

darolutamide

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Darolutamide
  • Docetaxel or cabazitaxel
  • (no location specified)
Feb 28, 2023

Prostate Cancer Trial in Worldwide (AZD5305, Darolutamide, No Treatment)

Not yet recruiting
  • Prostate Cancer
  • Melbourne, Australia
  • +7 more
Jul 3, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed

Recruiting
  • Prostate Cancer
  • +4 more
  • Darolutamide
  • metastasis-directed treatment
  • Aalst, Belgium
  • +6 more
Jan 25, 2023

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Darolutamide
  • +4 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Testosterone Cypionate
  • Darolutamide
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

Recruiting
  • Castrate Resistant Prostate Cancer
  • Chicago, Illinois
  • +2 more
Jul 19, 2022

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Breast Cancer Female, Triple Negative and Androgen Receptor Positive Trial in Caen (Darolutamide, Capecitabine)

Active, not recruiting
  • Breast Cancer Female
  • Triple Negative and Androgen Receptor Positive
  • Caen, France
    Centre François Baclesse
Jan 3, 2022

Advanced Prostate Carcinoma, Cancer of Prostate, PSA Trial in Melbourne (Darolutamide, Radiotherapy)

Recruiting
  • Advanced Prostate Carcinoma
  • +3 more
  • Darolutamide
  • Radiotherapy
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Center
Aug 26, 2021

Prostate Cancer Trial in United States (Bicalutamide, GnRH Agonist, Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Stamford, Connecticut
  • +4 more
May 12, 2022

Metastatic Prostate Cancer Trial in Sydney, Melbourne (Dasatinib, Darolutamide)

Recruiting
  • Metastatic Prostate Cancer
  • Sydney, New South Wales, Australia
  • +1 more
May 3, 2022

Prostate Cancer Trial in Worldwide (Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog)

Recruiting
  • Prostate Cancer
  • Darolutamide
  • +3 more
  • Boston, Massachusetts
  • +74 more
Aug 17, 2022

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • San Diego, California
  • +25 more
Jan 10, 2023

Prostate Carcinoma Trial in United States (Darolutamide, Goserelin Acetate, Leuprolide Acetate)

Recruiting
  • Prostate Carcinoma
  • Darolutamide
  • +5 more
  • Duarte, California
  • +107 more
Jul 26, 2022

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Breast Cancer Female Trial in Canada, Germany, United States (darolutamide)

Completed
Has Results
  • Breast Cancer Female
  • darolutamide
  • Los Angeles, California
  • +13 more
Mar 19, 2020

Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-Sensitive Prostate Cancer
  • Tucson, Arizona
  • +192 more
Nov 6, 2023